Christopher W. Fulton

Array ( [id] => 6880571 [patent_doc_number] => 20010031858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides' [patent_app_type] => new [patent_app_number] => 09/769487 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16070 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031858.pdf [firstpage_image] =>[orig_patent_app_number] => 09769487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6884664 [patent_doc_number] => 20010038824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'Intranasal cyclic peptide formulations' [patent_app_type] => new [patent_app_number] => 09/765846 [patent_app_country] => US [patent_app_date] => 2001-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31439 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20010038824.pdf [firstpage_image] =>[orig_patent_app_number] => 09765846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 715846 [patent_doc_number] => 07053056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases' [patent_app_type] => utility [patent_app_number] => 09/765105 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42417 [patent_no_of_claims] => 130 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053056.pdf [firstpage_image] =>[orig_patent_app_number] => 09765105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623491 [patent_doc_number] => 20020016291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Cyclic peptides as potent and selective melanocortin-4 receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/761046 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4547 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016291.pdf [firstpage_image] =>[orig_patent_app_number] => 09761046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093454 [patent_doc_number] => 06825319 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome' [patent_app_type] => B1 [patent_app_number] => 09/743225 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 11971 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825319.pdf [firstpage_image] =>[orig_patent_app_number] => 09743225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1349475 [patent_doc_number] => 06583265 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Cyclosporins' [patent_app_type] => B1 [patent_app_number] => 09/701542 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10696 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 325 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583265.pdf [firstpage_image] =>[orig_patent_app_number] => 09701542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560747 [patent_doc_number] => 06437094 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/754216 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14282 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437094.pdf [firstpage_image] =>[orig_patent_app_number] => 09754216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721523 [patent_doc_number] => 20030055213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Endothelin-antagonizing peptide' [patent_app_type] => new [patent_app_number] => 09/750754 [patent_app_country] => US [patent_app_date] => 2001-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26783 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055213.pdf [firstpage_image] =>[orig_patent_app_number] => 09750754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6279614 [patent_doc_number] => 20020107389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Conjugates of chemically defined non-polymeric valency platform molecules and biologically active molecules' [patent_app_type] => new [patent_app_number] => 09/752533 [patent_app_country] => US [patent_app_date] => 2000-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 31376 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107389.pdf [firstpage_image] =>[orig_patent_app_number] => 09752533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1239997 [patent_doc_number] => 06686336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents' [patent_app_type] => B2 [patent_app_number] => 09/746555 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7870 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686336.pdf [firstpage_image] =>[orig_patent_app_number] => 09746555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623681 [patent_doc_number] => 20020016298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Somatostatin antagonists and agonists that act at the sst subtype 2 receptor' [patent_app_type] => new [patent_app_number] => 09/747437 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14755 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016298.pdf [firstpage_image] =>[orig_patent_app_number] => 09747437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391907 [patent_doc_number] => 06544951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-08 [patent_title] => 'C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases' [patent_app_type] => B2 [patent_app_number] => 09/745204 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28221 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544951.pdf [firstpage_image] =>[orig_patent_app_number] => 09745204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1124302 [patent_doc_number] => 06794490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-21 [patent_title] => 'Lipopeptides as antibacterial agents' [patent_app_type] => B2 [patent_app_number] => 09/739535 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13087 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794490.pdf [firstpage_image] =>[orig_patent_app_number] => 09739535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999674 [patent_doc_number] => 06911525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Lipopeptides as antibacterial agents' [patent_app_type] => utility [patent_app_number] => 09/738742 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16450 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 509 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911525.pdf [firstpage_image] =>[orig_patent_app_number] => 09738742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820692 [patent_doc_number] => 07408025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Lipopeptides as antibacterial agents' [patent_app_type] => utility [patent_app_number] => 09/737908 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22422 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408025.pdf [firstpage_image] =>[orig_patent_app_number] => 09737908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1292445 [patent_doc_number] => 06630569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Ectoparasiticide agents' [patent_app_type] => B1 [patent_app_number] => 09/719626 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6252 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630569.pdf [firstpage_image] =>[orig_patent_app_number] => 09719626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316280 [patent_doc_number] => 06608063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-19 [patent_title] => 'Pyrazine based inhibitors of glycogen synthase kinase 3' [patent_app_type] => B2 [patent_app_number] => 09/738040 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14744 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608063.pdf [firstpage_image] =>[orig_patent_app_number] => 09738040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1334990 [patent_doc_number] => 06596867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Tartrate salt of a substituted dipeptide as growth hormone secretagogue' [patent_app_type] => B2 [patent_app_number] => 09/734269 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11097 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596867.pdf [firstpage_image] =>[orig_patent_app_number] => 09734269 [rel_patent_id] =>[rel_patent_doc_number] =>)